Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.

Moolec Science SA

WARWICK, GB / ACCESS NEWSWIRE / JUNE 18, 2025 / MOOLEC SCIENCE LIMITED A WHOLLY-OWNED SUBSIDIARY OF MOOLEC SCIENCE SA (NASDAQ:MLEC; "THE COMPANY"; "MOOLEC"), A SCIENCE-BASED FOOD INGREDIENT COMPANY FOCUSED ON PRODUCING ANIMAL PROTEINS AND NUTRITIONAL OILS IN PLANTS, ANNOUNCED TODAY THAT IT HAS RECEIVED A NOTICE OF ALLOWANCE FROM THE UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO) FOR ITS PROPRIETARY GROUNDBREAKING PIGGY SOOY TECHNOLOGY - SOYBEAN PLANT ENGINEERED TO EXPRESS HIGH LEVELS OF PORCINE HEMEPROTEINS IN THEIR SEEDS. MOOLEC SCIENCE LOGO PIGGY SOOY IS THE FIRST PATENTED SOYBEAN TECHNOLOGY DESIGNED TO PRODUCE HIGH LEVELS OF PORCINE HEMEPROTEINS DIRECTLY IN THE SEEDS.

MOOLEC SCIENCE SECURES CORE U.S. PATENT FOR PIGGY SOOY(TM), SOYBEAN EXPRESSING UP TO 30% OF ANIMAL PROTEIN

GRAND CAYMAN, CAYMAN ISLANDS / ACCESS NEWSWIRE / JUNE 17, 2025 / MOOLEC SCIENCE SA (NASDAQ:MLEC) ("THE COMPANY"; "MOOLEC"), A SCIENCE-BASED FOOD INGREDIENT COMPANY FOCUSED ON PRODUCING ANIMAL PROTEINS AND NUTRITIONAL OILS IN PLANTS, TODAY ANNOUNCED THE SUCCESSFUL CLOSING OF ITS PREVIOUSLY ANNOUNCED STRATEGIC BUSINESS COMBINATION (THE "BUSINESS COMBINATION") WITH BIOCERES GROUP LIMITED ("BIOCERES GROUP"), GENTLE TECHNOLOGIES CORP ("GENTLE TECH"), AND NUTRECON LLC ("NUTRECON"). WITH THE CLOSING, MOOLEC EMERGES AS THE PARENT COMPANY OF A SIGNIFICANTLY EXPANDED AND ENHANCED ENTERPRISE AT THE FOREFRONT OF SUSTAINABLE LIFE SCIENCES AND FOOD-TECH INNOVATION.

MOOLEC SCIENCE ANNOUNCES SUCCESSFUL CLOSING OF BUSINESS COMBINATION, EXPANDING ACROSS LIFE SCIENCES AND FOOD-TECH

GRAND CAYMAN, CAYMAN ISLANDS / ACCESS NEWSWIRE / JUNE 11, 2025 / MOOLEC SCIENCE SA (NASDAQ:MLEC) "THE COMPANY"; "MOOLEC"), A SCIENCE-BASED FOOD INGREDIENT COMPANY FOCUSED ON PRODUCING ANIMAL PROTEINS AND NUTRITIONAL OILS IN PLANTS, TODAY ANNOUNCED THAT IT REGAINED COMPLIANCE WITH LISTING RULE 5550(A)(2) (THE "BID PRICE RULE"), AS REQUIRED BY THE NASDAQ HEARINGS PANEL'S ("PANEL") DECISION DATED APRIL 3, 2025. ON MAY 14, 2025, THE COMPANY EFFECTED A 1-FOR-10 REVERSE STOCK SPLIT, AND THE COMMON SHARES HAVE SINCE HAD A CLOSING BID PRICE OF AT LEAST $1.

MOOLEC SCIENCE REGAINS NASDAQ COMPLIANCE

LUXEMBOURG, LU / ACCESS NEWSWIRE / MAY 12, 2025 / MOOLEC SCIENCE SA (NASDAQ:MLEC; THE "COMPANY" OR "MOOLEC"), A SCIENCE-BASED FOOD INGREDIENT COMPANY FOCUSED ON PRODUCING ANIMAL PROTEINS AND NUTRITIONAL OILS IN PLANTS, TODAY ANNOUNCED THAT, IN ACCORDANCE WITH THE RESOLUTIONS PASSED AT THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS HELD ON APRIL 22, 2025, AND THE RESOLUTIONS ADOPTED BY THE COMPANY'S BOARD OF DIRECTORS ON THE SAME DATE, THE COMPANY HAS APPROVED A REVERSE STOCK SPLIT AT A CONSOLIDATION RATIO OF ONE-FOR-TEN (1-FOR-10). AS A RESULT, EVERY TEN ORDINARY SHARES OF THE COMPANY, WITH A PAR VALUE OF US$0.01 PER SHARE (THE "SHARES"), ISSUED AND OUTSTANDING WILL AUTOMATICALLY, AND WITHOUT ANY ACTION REQUIRED ON THE PART OF THE HOLDERS, BE CONSOLIDATED INTO ONE VALIDLY ISSUED, FULLY PAID, AND NON-ASSESSABLE SHARE, WITH NO CHANGE TO THE PAR VALUE PER SHARE (THE "REVERSE STOCK SPLIT").

MOOLEC SCIENCE ANNOUNCES EFFECTIVENESS OF REVERSE STOCK SPLIT

LUXEMBOURG, LU / ACCESS NEWSWIRE / APRIL 21, 2025 / MOOLEC SCIENCE SA (NASDAQ:MLEC) ("THE COMPANY" OR "MOOLEC"), A SCIENCE-BASED FOOD INGREDIENT COMPANY FOCUSED ON PRODUCING ANIMAL PROTEINS AND NUTRITIONAL OILS IN PLANTS, TODAY ANNOUNCED THAT IT HAS ENTERED INTO A BUSINESS COMBINATION AGREEMENT (THE "BCA") WITH BIOCERES GROUP LIMITED ("BIOCERES GROUP") AND OTHER RELATED ENTITIES IN AN ALL-STOCK TRANSACTION (THE "BUSINESS COMBINATION"). SUBJECT TO THE TERMS AND CONDITIONS OF THE BCA, WHICH WAS SIGNED ON APRIL 17, 2025, SEVERAL PARTIES WILL TRANSFER THEIR RESPECTIVE HOLDINGS IN BIOCERES GROUP, NUTRECON LLC ("NUTRECON"), AND GENTLE TECHNOLOGIES CORP ("GENTLE TECH", AND TOGETHER WITH BIOCERES GROUP AND NUTRECON, THE "CONTRIBUTED ENTITIES"), RESULTING IN AN ENLARGED CORPORATE STRUCTURE WITH MOOLEC AS THE PARENT COMPANY.

MOOLEC SCIENCE ENTERS INTO TRANSFORMATIONAL TRANSACTION EXPANDING ACROSS MULTIPLE TECHNOLOGY PLATFORMS

LUXEMBOURG, LU / ACCESS NEWSWIRE / MARCH 17, 2025 / MOOLEC SCIENCE SA (NASDAQ:MLEC), A PUBLIC LIMITED LIABILITY COMPANY (SOCIT ANONYME) GOVERNED BY THE LAWS OF THE GRAND DUCHY OF LUXEMBOURG, HAVING ITS REGISTERED OFFICE AT 17, BOULEVARD F.W. RAIFFEISEN, L-2411 LUXEMBOURG, GRAND DUCHY OF LUXEMBOURG, AND REGISTERED WITH THE LUXEMBOURG REGISTER OF COMMERCE AND COMPANIES (REGISTRE DE COMMERCE ET DES SOCITS DE LUXEMBOURG) UNDER REGISTRATION NUMBER B268440 ("MOOLEC," THE "COMPANY," "WE," "US" OR "OUR") RECEIVED A LETTER ON MARCH 11, 2025 (THE "DETERMINATION LETTER"), FROM THE STAFF OF THE LISTING QUALIFICATIONS DEPARTMENT (THE "STAFF") OF THE NASDAQ STOCK MARKET LLC ("NASDAQ") NOTIFYING THE COMPANY THAT, AS THE CLOSING BID PRICE OF ITS LISTED SECURITIES HAS REMAINED AT LESS THAN $1.00 PER SHARE OVER 30 CONSECUTIVE BUSINESS DAYS AS OF SEPTEMBER 10, 2024, AND HAS NOT INCREASED TO $1.00 FOR MORE THAN 10 CONSECUTIVE BUSINESS DAYS THEREAFTER, THE COMPANY HAS NOT REGAINED COMPLIANCE WITH NASDAQ LISTING RULE 5550(A)(2).

MOOLEC RECEIVED NASDAQ STAFF DETERMINATION LETTER

LUXEMBOURG / ACCESSWIRE / OCTOBER 16, 2024 / MOOLEC SCIENCE SA (NASDAQ:MLEC) ("THE COMPANY"), A LEADER IN MOLECULAR FARMING TECHNOLOGY, ANNOUNCED TODAY THAT THE U.S. DEPARTMENT OF AGRICULTURE'S ("USDA") ANIMAL AND PLANT HEALTH INSPECTION SERVICE ("APHIS") HAS COMPLETED ITS REGULATORY STATUS REVIEW ("RSR") FOR THE COMPANY'S GENETICALLY ENGINEERED ("GE") PEAS WHICH PRODUCE IRON THROUGH BOVINE MEAT PROTEINS. THIS IS THE THIRD REGULATORY CLEARANCE FROM USDA-APHIS ACHIEVED BY MOOLEC IN AN 18-MONTH WINDOW, ALONGSIDE ITS GENETICALLY ENGINEERED SAFFLOWER AND SOYBEAN FOR GLASO AND PIGGY SOOY PRODUCTS, RESPECTIVELY.

MOOLEC HAS RECEIVED USDA APPROVAL FOR THE FIRST GENETICALLY MODIFIED PEA IN HISTORY

LUXEMBOURG / ACCESSWIRE / OCTOBER 2, 2024 / MOOLEC SCIENCE SA (NASDAQ:MLEC) ("THE COMPANY"; "MOOLEC"), A SCIENCE-BASED FOOD INGREDIENT COMPANY FOCUSED ON PRODUCING ANIMAL PROTEINS AND NUTRITIONAL OILS IN PLANTS, TODAY REPORTED ITS BUSINESS UPDATE FOR THE FOURTH QUARTER OF FISCAL YEAR 2024 ENDED JUNE 30, 2024. MOOLEC SCIENCE LOGO THE MAIN HIGHLIGHTS OF MOOLEC'S FOURTH QUARTER ARE AS FOLLOWS: GLASO: THE COMPANY ANNOUNCED AN OFFTAKE AGREEMENT WITH A MAJOR GLOBAL CPG FOOD AND PET FOOD COMPANY AND AN R&D COLLABORATION AGREEMENT WITH BUNGE.

MOOLEC SCIENCE PRESENTS FISCAL YEAR 2024 ANNUAL BUSINESS UPDATE

LUXEMBOURG / ACCESSWIRE / SEPTEMBER 25, 2024 / MOOLEC SCIENCE SA (NASDAQ:MLEC)("THE COMPANY"; "MOOLEC"), A SCIENCE-BASED FOOD INGREDIENT COMPANY FOCUSED ON PRODUCING ANIMAL PROTEINS AND NUTRITIONAL OILS IN PLANTS, ANNOUNCED TODAY THAT IT WILL RELEASE ITS BUSINESS UPDATE FOR THE FOURTH QUARTER AND FULL FISCAL YEAR 2024 ON WEDNESDAY, OCTOBER 2, 2024, BEFORE THE MARKET OPENS. MOOLEC SCIENCES LOGO MOOLEC'S CHIEF EXECUTIVE OFFICER GASTN PALADINI, CHIEF FINANCIAL OFFICER JOS LPEZ LECUBE, AND CHIEF SCIENCE OFFICER AMIT DHINGRA, WILL HOST A LIVE CONFERENCE CALL, FOLLOWED BY A QUESTION-AND-ANSWER SESSION, ON WEDNESDAY, OCTOBER 2, 2024 AT 08:30AM ET.

MOOLEC SCIENCE TO HOST FOURTH QUARTER FISCAL YEAR 2024 BUSINESS UPDATE CONFERENCE CALL

LUXEMBOURG / ACCESSWIRE / SEPTEMBER 13, 2024 / MOOLEC SCIENCE SA (NASDAQ:MLEC) ("THE COMPANY", "MOOLEC"), A SCIENCE-BASED FOOD INGREDIENT COMPANY, ANNOUNCED TODAY THAT IT RECEIVED A LETTER (THE "NASDAQ BID PRICE LETTER") FROM NASDAQ NOTIFYING THE COMPANY THAT, FOR THE LAST 30 CONSECUTIVE BUSINESS DAYS, THE CLOSING BID PRICE FOR THE COMPANY'S ORDINARY SHARES HAS BEEN BELOW THE MINIMUM $1.00 PER SHARE REQUIRED FOR CONTINUED LISTING ON THE NASDAQ CAPITAL MARKET PURSUANT TO NASDAQ LISTING RULE 5550(A)(2). THE NASDAQ BID PRICE LETTER HAS NO IMMEDIATE EFFECT ON THE LISTING OF THE COMPANY'S COMMON STOCK, AND ITS COMMON STOCK WILL CONTINUE TO TRADE ON THE NASDAQ CAPITAL MARKET UNDER THE SYMBOL "MLEC".

Moolec Science SA

MLEC

Price

Financials Overview

Financial Reports

No items found.

Press Releases

Moolec Science SA

MLEC.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

MLEC